Danaher reports Q2 non-GAAP EPS of $1.94, exceeding expectations by $0.09, with revenue up 6.8% year-over-year.
Danaher posted Q2 non-GAAP earnings per share of $1.94, beating estimates by $0.09, as revenue rose 6.8% year-over-year to $6.3 billion. The company surpassed revenue expectations by $130 million, driven by growth in core revenue.
Non-GAAP core revenue increased 3.0% year-over-year, while core revenue excluding respiratory testing climbed 4.5%. The results reflect stronger demand across key segments, though respiratory testing continued to weigh on performance.
The company did not disclose immediate market reactions in the release.